Activating brain lymphatics to explore new treatments for Alzheimer's disease
Multiplex meningeal lymphatic activation for Alzheimer’s disease
This study is looking at new ways to help people with Alzheimer's disease by boosting the brain's lymphatic system, using methods like special proteins, gene therapy, and stem cells, to see if these can improve thinking and memory skills.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Southern California NIH-funded |
| Lab location | 1 site (Los Angeles, UNITED STATES) |
| Project ID | NIH-11163459 on NIH RePORTER |
What this research studies
This research investigates how activating the brain's lymphatic system may provide new therapeutic strategies for Alzheimer's disease (AD). The team will explore three innovative methods to enhance lymphatic function, including delivering a specific protein, injecting a gene therapy, and implanting stem cells. By understanding the relationship between craniosynostosis, a skull disorder, and AD, the researchers aim to uncover potential risk factors and treatment pathways. Patients may benefit from these approaches if they demonstrate effectiveness in improving cognitive function.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals with Alzheimer's disease or those at risk due to craniosynostosis.
Not a fit: Patients with Alzheimer's disease who do not have any craniosynostosis-related conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that improve cognitive function in patients with Alzheimer's disease.
How similar studies have performed: While the activation of brain lymphatics is a relatively novel approach, preliminary studies have shown promise in related areas, suggesting potential for success.
Where this research is happening
Los Angeles, UNITED STATES
- University of Southern California — Los Angeles, United States (Active)
Researchers
- Principal investigator: Chen, Jianfu — University of Southern California
- Study coordinator: Chen, Jianfu
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.